[1] |
World Health Organization . Use of high burden country lists for TB by WHO in the post 2015. Geneva: World Health Organization, 2015.
|
[2] |
Mulder C, Mgode GF, Ellis H , et al. Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert ® MTB/RIF . Int J Tuberc Lung Dis, 2017,21(11):1127-1133.
|
[3] |
Campos LC, Rocha MV, Willers DM , et al. Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence. PLoS One, 2016,11(1):e0147933.
doi: 10.1371/journal.pone.0147933
URL
|
[4] |
World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
|
[5] |
Tostmann A, Kik SV, Kalisvaart NA , et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis, 2008,47(9):1135-1142.
doi: 10.1086/594992
URL
|
[6] |
World Health Organization . Xpert MtB/RIF assay for the dia-gnosis of pulmonary and extrapulmonary TB in adults and children. Geneva: World Health Organization, 2014.
|
[7] |
Helb D, Jones M, Story E , et al. Rapid Detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol, 2010,48(1):229-237.
doi: 10.1128/JCM.01463-09
URL
|
[8] |
García-Basteiro AL, Saavedra B, Cobelens F . The Good,the Bad and the Ugly of the Next-Generation Xpert Mtb/Rif ® Ultra Test for Tuberculosis Diagnosis . Arch Bronconeumol, 2017,53(12):665-666.
|
[9] |
Steingart KR, Schiller I, Horne DJ , et al.Xpert ® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 2014,( 1):CD009593.
|
[10] |
Akanbi MO, Achenbach C, Taiwo B , et al. Evaluation of gene Xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study. BMC Pulm Med, 2017,17(1):87.
doi: 10.1186/s12890-017-0430-6
URL
|
[11] |
Lawn SD, Brooks SV, Kranzer K , et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antire-troviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med, 2011,8(7):e1001067.
doi: 10.1371/journal.pmed.1001067
URL
|
[12] |
Sohn H, Aero AD, Menzies D , et al. Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis, 2014,58(7):970-976.
doi: 10.1093/cid/ciu022
URL
|
[13] |
Yuan M, Lyu Y, Chen ST , et al. Evaluation of Xpert MTB/RIF for the Diagnosis of Extrapulmonary Tuberculosis in China. Biomed Environ Sci, 2016,29(8):599-602.
|
[14] |
Maynard-Smith L, Larke N, Peters JA , et al. Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis, 2014,14:709.
doi: 10.1186/s12879-014-0709-7
URL
|
[15] |
Rice JP, Seifert M, Moser KS , et al. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting. PLoS One, 2017,12(10):e0186139.
doi: 10.1371/journal.pone.0186139
URL
|
[16] |
Albert H, Nathavitharana RR, Isaacs C , et al. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J, 2016,48(2):516-525.
doi: 10.1183/13993003.00543-2016
URL
|
[17] |
Huang H, Zhang Y, Li S , et al. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study. Microb Drug Resist, 2017. In press.
|
[18] |
Zetola NM, Shin SS, Tumedi KA , et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol, 2014,52(7):2422-2429.
doi: 10.1128/JCM.02489-13
URL
|
[19] |
Rufai SB, Kumar P, Singh A , et al. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J Clin Microbiol, 2014,52(6):1846-1852.
doi: 10.1128/JCM.03005-13
URL
|
[20] |
Köser CU, Feuerriegel S, Summers DK , et al. Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance. Antimicrob Agents Chemother, 2012,56(12):6080-6087.
doi: 10.1128/AAC.01641-12
URL
|
[21] |
Cayci YT, Bilgin K, Coban AY , et al. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF. Mem Inst Oswaldo Cruz, 2017,112(11):756-759.
doi: 10.1590/0074-02760170051
URL
pmid: 5661898
|
[22] |
Williamson DA, Basu I, Bower J , et al. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifam-picin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis, 2012,74(2):207-209.
doi: 10.1016/j.diagmicrobio.2012.06.013
URL
|
[23] |
World Health Organization . WHO meeting report of a technical expert consultation: A multicentre non-inferiority analysis of Xpert MTB/RIF ultra compared to Xpert MTB/RIF, 2017. Geneva: World Health Organization, 2017.
|
[24] |
Bahr NC, Nuwagira E, Evans EE , et al. Team A-CT. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2018,18(1):68-75.
doi: 10.1016/S1473-3099(17)30474-7
URL
|
[25] |
Kendall EA, Schumacher SG, Denkinger CM , et al. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study. PLoS Med, 2017,14(12):e1002472.
doi: 10.1371/journal.pmed.1002472
URL
|
[26] |
Chakravorty S, Simmons AM, Rowneki M , et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing.MBio, 2017, 8(4): pii:e00812-817.
|
[27] |
Chakravorty S, Kothari H, Aladegbami B , et al. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J Clin Microbiol, 2012,50(7):2194-2202.
doi: 10.1128/JCM.00143-12
URL
|
[28] |
World Health Organization . Frequently asked questions about the WHO Technical Expert Consultation findings on Xpert ® MTB/RIF Ultra . Geneva: World Health Organization, 2017.
|
[29] |
Foundation for Innovative New Diagnostics( FIND). A multicentre non-inferiority diagnostic accuracy study of the ultra assay compared to the Xpert MTB/RIF assay. Geneva: Foundation for Innovative New Diagnostics, 2017.
|
[30] |
Cox HS, Mbhele S, Mohess N , et al. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial. PLoS Med, 2014,11(11):e1001760.
doi: 10.1371/journal.pmed.1001760
URL
|
[31] |
Churchyard GJ, Stevens WS, Mametja LD , et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health, 2015,3(8):e450-457.
doi: 10.1016/S2214-109X(15)00100-X
URL
|
[32] |
Durovni B , Saraceni V,van den Hof S,et al. Correction:Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial. PLoS Med, 2015,12(12):e1001928.
doi: 10.1371/journal.pmed.1001928
URL
|
[33] |
Sachdeva KS, Raizada N, Sreenivas A , et al. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India. PLoS One, 2015,10(5):e0126065.
doi: 10.1371/journal.pone.0126065
URL
|
[34] |
张爱梅, 李峰, 刘旭辉 , 等. 结核分枝杆菌/利福平耐药实时荧光定量核酸扩增检测在肺外结核中的诊断价值. 中华传染病杂志, 2016,34(3):174-179.
doi: 10.3760/cma.j.issn.1000-6680.2016.01.009
URL
|
[35] |
孙庆燕, 孙冰, 张娟 . GeneXpert MTB/RIF在诊断肺内及肺外结核病的应用评价. 医学检验与临床, 2017,28(10):27-30.
|
[36] |
张炜平, 秦超 . 支气管肺泡灌洗液 Xpert MTB/RIF检验在痰涂阴肺结核发现中的价值. 中国生化药物杂志, 2017,37(2):302-304.
doi: 10.3969/j.issn.1005-1678.2017.02.095
URL
|
[37] |
张海晴, 刘成永, 周冬青 , 等. GeneXpert MTB/RIF系统在结核性胸膜炎快速诊断中应用价值. 北京医学, 2016,38(7):739-741.
|